BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sevastre AS, Buzatu IM, Baloi C, Oprita A, Dragoi A, Tataranu LG, Alexandru O, Tudorache S, Dricu A. ELTD1-An Emerging Silent Actor in Cancer Drama Play. Int J Mol Sci 2021;22:5151. [PMID: 34068040 DOI: 10.3390/ijms22105151] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Sun B, Zhong FJ. ELTD1 Promotes Gastric Cancer Cell Proliferation, Invasion and Epithelial-Mesenchymal Transition Through MAPK/ERK Signaling by Regulating CSK. Int J Gen Med 2021;14:4897-911. [PMID: 34475781 DOI: 10.2147/IJGM.S325495] [Reference Citation Analysis]
2 Schneider B, William D, Lamp N, Zimpfer A, Henker C, Classen CF, Erbersdobler A. The miR-183/96/182 cluster is upregulated in glioblastoma carrying EGFR amplification. Mol Cell Biochem 2022. [PMID: 35486213 DOI: 10.1007/s11010-022-04435-y] [Reference Citation Analysis]
3 Sevastre AS, Costachi A, Tataranu LG, Brandusa C, Artene SA, Stovicek O, Alexandru O, Danoiu S, Sfredel V, Dricu A. Glioblastoma pharmacotherapy: A multifaceted perspective of conventional and emerging treatments (Review). Exp Ther Med 2021;22:1408. [PMID: 34676001 DOI: 10.3892/etm.2021.10844] [Reference Citation Analysis]